Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. As of March 15th, there was short interest totalling 2,670,000 shares, an increase of 80.4% from the February 28th total of 1,480,000 shares. Previously, he was Vice-President for Digital Health Technologies and Data Sciences at Biogen, a group that he established in 2015 to discover insights and create value for Biogen and its patients. Seer, Inc. has a collaboration program agreement with Discovery Life Sciences, LLC; and commercial agreements with Bruker Scientific LLC and Thermo Electron North America LLC. Seer, Inc. was founded in 2017 and is headquartered in Redwood City, California. Do Not Sell My Information. The company's platform captures and translates molecular insights from the proteome with improved accuracy and speed, enabling healthcare professionals to detect cancer and neurological SEER BIOSCIENCES, INC. is company based in SOUTH SAN FRANCISCO, CA 94080, California. Approximately 7.6% of the company's stock are sold short. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Market / Outlet Security Exchange Symbol Type; Seer / Seer, Inc. Class A Common Stock: US XNAS: SEER: EQ0000000059232189 Glassdoor gives you an inside look at what it's like to work at Seer, including salaries, reviews, office photos, and more. Seer | 2,018 followers on LinkedIn. Fundamental company data provided by Zacks Investment Research. The total size of the offering was $175,000,013 based on an initial share price of $19.00. Seer stock-based compensation from 1970 to 1969. Learn about financial terms, types of investments, trading strategies and more. Seer, Inc. has a collaboration program agreement with Discovery Life Sciences, LLC; and commercial agreements with Bruker Scientific LLC and Thermo Electron North America LLC. Redwood City-based Seer's stock nearly tripled in IPO, valuing company at over $3B. Vote “Underperform” if you believe SEER will underperform the S&P 500 over the long term. “We are very excited to partner with SCIEX to enable new possibilities in unbiased, deep, and rapid proteomics at scale,” said Omead Ostadan, President and Chief Operating Officer at Seer. Artal Group S.A. added to a holding in IGM Biosciences Inc by 74.19%. Seer’s Proteograph Product Suite is for research use only and is not intended for diagnostic procedures.For more information, please visit www.seer.bio. Based on an average daily trading volume, of 474,100 shares, the days-to-cover ratio is […] This suggests a possible upside of 30.3% from the stock's current price. Based on an average daily volume of 474,100 shares, the days-to-cover ratio is currently 5.6 days. The company issued 8,800,000 shares at a price of $16.00-$18.00 per share. MarketBeat thinks these five stocks may be even better buys.View MarketBeat's top stock picks here. Currency in USD, Trade prices are not sourced from all markets. Delete or Cancel . Subscribe to Yahoo Finance Plus to view Fair Value for SEER. Please log in to your account or sign up in order to add this asset to your watchlist. Stock ... Pacific Biosciences of California, Inc. 3.06% ... Company Profile. 4 brokerages have issued 1 year price targets for Seer's shares. But most Americans won’t see what’s going on until it’s too late. The company reported ($0.54) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.48) by $0.06. Seer's lock-up period expires on Wednesday, June 2nd. In the past three months, Seer insiders have sold more of their company's stock than they have bought. Seer Biosciences has 19 executives. How Secure Should You Be With BlackBerry Stock? Added: IGM Biosciences Inc . (SEER) raised $150 million in an initial public offering (IPO) on Friday, December 4th 2020. Seer Inc (NASDAQ: SEER): Bought 77,391 shares of the life sciences company, representing about 0.04% of the ETF. But as Seer has not provided consistent financial data, and the stock also has no analyst forecast or coverage, its intrinsic value cannot be reliably calculated by extrapolating past data or using analyst consensus cash flow predictions. 02-16 sec.gov - UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. SEER Stock Price Chart Interactive Chart > SEER Price/Volume Stats. Seer, Inc., a life sciences company, engages in developing and commercializing products for researchers to unlock biological information. Forward-looking statements may involve known and unknown risks, uncertainties and other factors that may cause Seer’s actual results, performance or achievements to be materially different from those expressed or implied by the forward-looking statements. The combined product offering will enable labs of all types to combine highly sensitive mass spectrometry with unbiased, deep proteomics studies at scale, delivering new levels of insight, speed, and sensitivity. MarketBeat just released five new trading ideas, but Seer wasn't one of them. Learn more. MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Media Inquiries:Karen Possematopr@seer.bio Investor Inquiries: Carrie Mendivilinvestor@seer.bio, Discover new investment ideas by accessing unbiased, in-depth investment research, NasdaqGS - NasdaqGS Real Time Price. Seer, Inc. was incorporated in 2017 and is headquartered in Redwood City, California. Our telephone number is 650-543-0000. This agreement will enable Seer to market SCIEX mass spectrometry systems together with its Proteograph Product Suite. Seer, Inc. was incorporated in 2017 and is based in Redwood City, California. View our full suite of financial calendars and market data tables, all for free. We were incorporated in Delaware in 2017 as Seer Biosciences, Inc. On what stock exchange are Seer shares traded, and what is the ticker symbol? Shares of our Class A common stock are traded on the Nasdaq Global Select Market exchange. First name Last name. Seer has only been the subject of 1 research reports in the past 90 days. View Seer's earnings history. © American Consumer News, LLC dba MarketBeat® 2010-2021. Compare Top Brokerages Here. MarketBeat's community ratings are surveys of what our community members think about Seer and other stocks. View which stocks are hot on social media with MarketBeat's trending stocks report. All rights reserved. This partnership with Seer will continue to expand the boundaries of what’s possible in proteomics, and to open up new realms of biological insight.” Seer and SCIEX look forward to future collaborations, such as through establishing centers of excellence using both technologies, optimizing workflows for key applications, and aligning development efforts. © 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Get daily stock ideas top-performing Wall Street analysts. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. Shares of SEER can be purchased through any online brokerage account. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: You have already added five stocks to your watchlist. This company was established on 2018-02-23 and registered under entity number C4117079.SEER BIOSCIENCES, INC. was founded1098 days ago. View analysts' price targets for Seer or view top-rated stocks among Wall Street analysts. View our earnings forecast for Seer. View Seer's Short Interest. Our ticker is SEER. All rights reserved. Want to see which stocks are moving? Vote “Outperform” if you believe SEER will outperform the S&P 500 over the long term. The holding were 1,200,000 shares as of 2020-12-31. Seer has received 2 “outperform” votes. SEER BIOSCIENCES, INC. SEER : Where To Trade SEER. The company's average rating score is 2.50, and is based on 2 buy ratings, 2 hold ratings, and no sell ratings. Their needs and applications push the absolute limits of what can be achieved with mass spectrometry technology. All content is posted anonymously by employees working at Seer. A high-level overview of Seer, Inc. (SEER) stock. This is the Seer company profile. Their forecasts range from $60.00 to $75.00. Seer has received 60.00% “underperform” votes from our community. view top-rated stocks among Wall Street analysts, Receive Analysts' Upgrades and Downgrades Daily. 1)* SELECTA BIOSCIENCES, INC. (Name of Issuer) Common Stock, par value $0.0001 par value per share (Title of Class of … Receive a free world-class investing education from MarketBeat. 326 E 8th St #105, Sioux Falls, SD 57103 | [email protected] | (844) 978-6257 See what's happening in the market right now with MarketBeat's real-time news feed. Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter. The company develops Proteograph Product Suite, an integrated solution that comprises consumables, an automation instrumentation, and software that provides workflow to make proteomic profiling, and the analysis of the samples needed to characterize the nature of the proteome. Seer trades on the NASDAQ under the ticker symbol "SEER.". Previously, he was Vice-President for Digital Health Technologies and Data Sciences at Biogen, a group that he established in 2015 to discover insights and create value for Biogen and its patients. MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools. It is designed to be efficient, easy-to-use, and to accurately survey thousands of proteins with precision. Seer, Inc. has a collaboration program agreement with Discovery Life Sciences, LLC; and commercial agreements with Bruker Scientific LLC and Thermo Electron North America LLC. Some companies that are related to Seer include AbCellera Biologics (ABCL), Sana Biotechnology (SANA), Abcam (ABCM), Cronos Group (CRON), BTG (BTG), Genus (GNS), Abcam (ABC), MorphoSys (MOR), ImmunityBio (IBRX), Nuvation Bio (NUVB), Immunocore (IMCR), Cullinan Management (CGEM), BioAtla (BCAB), Silverback Therapeutics (SBTX) and Vor Biopharma (VOR). Philip Ma is the Chief Business Officer for Seer. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. Seer, Inc. has a collaboration program agreement with Discovery Life Sciences, LLC; and commercial agreements with Bruker Scientific LLC and Thermo Electron North America LLC. Earlier today, Seer released financial results for the fourth quarter and full year ending December 31, 2020. Seer is a developer of a life sciences and health data platform intended to facilitate early, pre-symptomatic detection of chronic life-threatening diseases. J.P. Morgan, Morgan Stanley, BofA Securities and Cowen served as the underwriters for the IPO. Learn everything you need to know about successful options trading with this three-part video course. The company was formerly known as Seer Biosciences, Inc. and changed its name to Seer, Inc. in July 2018. It has a 52-week high of $86.55 and low of $38.37. Our principal executive offices are located at 3800 Bridge Parkway, Suite 102, Redwood City, California 94065. Hydrofarm Stock is a Compelling Domestic Cannabis Cultivation Play, 7 Electric Vehicle (EV) Stocks That Are Ready to Rebound, 7 Sports Betting Stocks That Will Shine Beyond March Madness, 7 Stocks That Cathie Wood is Buying And You Should Too, 7 Internet of Things Stocks That Are a Perfect Fit to Our Connected Future, 7 Undervalued Stocks That Deserve More Attention, 7 Semiconductor Stocks Set to Gain From the Chip Shortage, 7 Great Dividend Stocks to Buy For a Comfortable Retirement, 7 Penny Stocks That Don’t Care About Robinhood, 7 Hotel Stocks Just Waiting For the Vaccine, 7 Stocks to Watch When Student Debt Forgiveness Gets Passed, 7 Healthcare Stocks Delivering Innovation in 2021, Seer, Inc. (SEER) Misses Q4 EPS by 6c, Revenues Beat - StreetInsider.com, Seer's (SEER) CEO Omid Farokhzad on Q4 and Full Year 2020 Results - Earnings Call Transcript - Seeking Alpha, Seer, Inc. (SEER) Q4 2020 Earnings Call Transcript - The Motley Fool, Seer and SCIEX Sign Commercial Agreement to Offer End-to-End Unbiased Proteomics Solutions - Yahoo Finance, Seer, Inc. (NASDAQ:SEER) Short Interest Up 80.4% in March, Seer (NASDAQ:SEER) Posts Earnings Results, Misses Estimates By $0.06 EPS, Seer signs agreement with SCIEX to offer Proteomics Solutions - Seeking Alpha, Seer Reports Fourth Quarter and Full Year 2020 Financial Results and Fuels Commercial Progress in 2021 with New Collaborators and Partnerships - GlobeNewswire, Alibaba, Amazon, Palantir, Google, Takeda, Unity — What Cathie Wood's Ark Bought And Sold On Thursday - Yahoo Finance, SlashNext Launches Secure Risk Assessment to Detect Unseen Next Generation 2.0 Phishing Threats, Seer (SEER) Scheduled to Post Earnings on Monday, Greenberg Traurig's Bernadette Rappold to Serve on ABA SEER Webinar Panel: Analyzing Risk Assessment and Cumulative Risk Assessment, Greenberg Traurig's Bernadette Rappold to Serve on ABA SEER Webinar Panel: Analyzing Risk Assessment and Cumulative Risk Assessment - Yahoo Finance, Seer, Inc. (NASDAQ:SEER) Short Interest Update, Facebook reveals A.I. Here’s what’s coming. View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. SELB / Selecta Biosciences, Inc. / Mangrove Partners Master Fund, Ltd. - SC 13G/A Passive Investment. An unstoppable force is taking over our financial markets. Seer stock closed 3.74% higher at $40.18 on Friday and was up 1.42% in the after-hours. The broad applicability of the ImmTOR platform gives us the unique ability to address immunogenicity across indications, including enabling redosing of life saving gene therapies and restoring self-tolerance in autoimmune diseases. Current price ... Seer, Inc., a life sciences company, engages in developing nanoparticle technology solutions for researchers in the areas of proteomics information. According to analysts' consensus price target of $68.00, Seer has a forecasted upside of 30.3% from its current price of $52.18. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. You can opt out at any time. Identify stocks that meet your criteria using seven unique stock screeners. The company was formerly known as Seer Biosciences, Inc. and changed its name to Seer, Inc. in July 2018. We empower the scientific community through the power of proteomics. The stock is now traded at around $109.350000. The impact to a portfolio due to this purchase was 1.07%. Looking for new stock ideas? Forward-Looking Statements This press release contains “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, as amended. After the end of Seer's lock-up period, restrictions preventing company insiders and major shareholders from selling shares in the company will be lifted. These and other risks are described more fully in Seer’s filings with the Securities and Exchange Commission (“SEC”) and other documents that Seer subsequently files with the SEC from time to time. Seer, Inc. (NASDAQ:SEER) posted its quarterly earnings results on Sunday, March, 28th. | At Seer, we develop innovative solutions that act as a gateway to the proteome. Our Accessibility Statement Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Seer is scheduled to release its next quarterly earnings announcement on Monday, July 5th 2021. represents a big leap forward for computer vision - Fortune, Do Institutions Own Seer, Inc. (NASDAQ:SEER) Shares? Research its history to confirm it's a solid investment against your financial goals. Hashtag: #SEERBIOSCIENCES,INC. This is quite a rare situation as 89% of companies covered by Simply Wall St do have a valuation analysis. The company was formerly known as Seer Biosciences, Inc. and changed its name to Seer, Inc. in July 2018. - Yahoo Finance. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. SEER stock quote, chart and news. The company was formerly known as Seer Biosciences, Inc. and changed its name to Seer, Inc. in July 2018. Seer stock closed 8.14% lower at $41.74 on Thursday. Seer, Inc., a life sciences company, engages in developing and commercializing products for researchers to unlock biological information. As of March 15th, there was short interest totaling 2,670,000 shares, an increase of 80.4% from the February 28th total of 1,480,000 shares. Our goal is to make it possible for labs of all types to add unbiased proteomics to their studies, whether they want to add discovery to their targeted analysis, add proteomics data to genomics studies, or expand their omics repertoire, we are building the partnerships to make this happen faster.” Dominic Gostick, Vice President & General Manager, LC/MS Business for SCIEX, said, “At SCIEX it is a priority to drive innovation through what we learn with our customers. ... Selecta Biosciences, Inc., a clinical-stage biopharmaceutical company, researches and develops nanoparticle immunomodulatory drugs for the treatment and prevention of human diseases. The company was formerly known as Seer Biosciences, Inc. and changed its name to Seer, Inc. in July 2018. The latest closing stock price for Seer as of March 22, 2021 is 52.54.. Stock Price Prediction: Update at 5:00pm EST The combination of the Proteograph Product Suite with SCIEX systems provides new options for customers to add unbiased, deep proteomics analysis to their studies, allowing them to accelerate their research, and for existing proteomics labs to expand their application set. Quick Take. Title goes here. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. View analyst ratings for Seer or view top-rated stocks. Earnings for Seer are expected to grow in the coming year, from ($1.00) to ($0.74) per share. Seer, a liquid biopsy company aimed at querying the body’s proteome, has emerged from stealth with $36 million in funding to develop early-warning tests for cancer and neurological diseases. Learn more. You may vote once every thirty days. Seer (NASDAQ:SEER) has filed to raise $150 million in an IPO of its Class A common stock, according to an S-1 registration statement.. Seer does not have a long track record of dividend growth. Seer saw a increase in short interest during the month of March. Get Seer, Inc. (California)'s stock price today. Seer has received a consensus rating of Buy. Seer, Inc. (California) engages in the development of proprietary engineered nanoparticles to provide access across the proteome. One share of SEER stock can currently be purchased for approximately $52.18. © 2021 Verizon Media. Shareseer is a research tool to efficiently view company filings and financials, insider transactions and institutional holdings. Seer's management team includes the following people: M.D., Founder, CEO & Chair of the Board of Directors, Start Your Risk-Free Trial Subscription Here, 3 Reasons Why Microsoft Stock Belongs in Your Portfolio, 3 Pet Stocks You’ll Love As Much As Your Furry Friends, Pinterest Stock is a Sticky Drama-Free Reopening Benefactor, Furniture Manufacturers See Booming Business During Pandemic, Italy may be in Easter lockdown, but the party's on at sea, Frontier Airlines hopes IPO rides wave of travel recovery, Here’s Where to Buy Corning Stock as Re-Opening Tailwinds Accelerate, Six (6) Reasons Why Bitcoin Will Hit $90,000 This Year, Romeo Power Is a SPAC Stock You Can Fall in Love With. Philip Ma is the Chief Business Officer for Seer. Unlocking the Power of Biologics. Do Institutions Own Seer, Inc. (NASDAQ:SEER) Shares? The company is classified as Active. that is already improving Instagram video recommendations - Fortune, Bruker Announces New Results in Deep, Unbiased Plasma Proteomics, PaSER 1.1 Software and New Cross-linking Consumables at US HUPO 2021 - StreetInsider.com, Facebook says its new Instagram-trained A.I. Seer, Inc. was founded in 2017 and is headquartered in Redwood City, California. Seer has a market capitalization of $3.18 billion. We were incorporated in Delaware on March 16, 2017, under the name Seer Biosciences, Inc., and changed our name to Seer, Inc. on July 16, 2018. SEER intends to sell 8.825 million shares of Class A stock at a midpoint price of $17.00 per share for gross proceeds of approximately $150 million, … Except to the extent required by law, Seer undertakes no obligation to update such statements to reflect events that occur or circumstances that exist after the date on which they were made. These statements include but are not limited to statements regarding Seer’s ability to successfully execute the development and commercialization of its Proteograph; or the combined solution offered by the commercial agreement, the ability of the combined product offering to enable labs to perform unbiased, deep proteomics studies at scale to deliver new levels of insight, speed, and sensitivity, to expand unbiased proteomics discovery efforts, expand application sets, and future collaborations. Export data to Excel for your own analysis. Portfolio Leveraging our ImmTOR™ platform to amplify the efficacy of biologic therapies. Seer, Inc. has a collaboration program agreement with Discovery Life Sciences, LLC; and commercial agreements with Bruker Scientific LLC and Thermo Electron North America LLC. The company was formerly known as Seer Biosciences, Inc. and changed its name to Seer, Inc. in July 2018. The all-time high Seer stock closing price was 84.06 on January 20, 2021.; The Seer 52-week high stock price is 86.55, which is 64.7% above the current share price. Seer, Inc. (NASDAQ:SEER) was the recipient of a significant increase in short interest during the month of March. To see all exchange delays and terms of use please see disclaimer. It intends to sell its products for research purposes, which cover academic institutions, life sciences, and research laboratories, as well as biopharmaceutical and biotechnology companies for non-diagnostic and non-clinical purposes. Seer is developing its Proteograph Product Suite, which is an integrated solution consisting of consumables, automation instrumentation and proprietary software that performs deep, unbiased proteomics analysis at scale in a matter of hours. The company develops Proteograph Product Suite, an integrated solution that comprises consumables, an automation instrumentation, and software that provides workflow to make proteomic profiling, and the analysis of the samples needed to … The consensus among Wall Street analysts is that investors should "buy" Seer stock. “By providing our customers with end-to-end workflows for large-scale proteomics studies, we are paving the way for labs to expand their proteomics discovery efforts. Seer Inc. Cl A company facts, information and financial ratios from MarketWatch. The company can be reached via phone at 650-543-0000. Seer to Report Fourth Quarter and Full Year 2020 Financial Results on March 29, 2021. (Add your “underperform” vote.). 4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Seer in the last year. Seer Biosciences; Please confirm your deletion . The purchase prices were between $47.41 and $115.03, with an estimated average price of $70.2. The company was formerly known as Seer Biosciences, Inc. and changed its name to Seer, Inc. in July 2018. The Proteograph Product Suite comprises Seer’s proprietary engineered nanoparticles, consumables, an automation instrument, and software that enables proteomics studies with an unprecedented combination of speed, scale, depth and breadth of data. The company was formerly known as Seer Biosciences, Inc. and changed its name to Seer, Inc. in July 2018. By Cromwell Schubarth – TechFlash Editor, Silicon Valley Business Journal . There are currently 2 hold ratings and 2 buy ratings for the stock. MarketBeat does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security. Find the stock by name or ticker symbol: SEER. Price chart and data for Seer are expected to grow in the development of proprietary engineered to... Purchase was 1.07 % St do have a long track record of dividend growth buy '' rating but... Have bought $ 0.00 in company stock and sold $ 59,060,018.00 in company.! Data and objective market analysis history to confirm it 's a solid investment your... A life sciences and health data platform intended to facilitate early, pre-symptomatic of! Your portfolio performance to leading indices and get personalized stock ideas based on an initial share seer biosciences stock and. Also get a free subscription to the Liberty through Wealth e-newsletter biological information, pre-symptomatic detection of chronic life-threatening.. Other stocks life sciences company, representing about 0.04 % of the was. Efficient, easy-to-use, and other stocks from the MarketBeat Idea Engine data! View analysts ' Upgrades and Downgrades daily 's happening in the after-hours health data platform intended to facilitate,. %... company Profile offering ( IPO ) on Friday and was up 1.42 in. A significant increase in short interest during the month of March 22, 2021 Mangrove Partners Master,. Quarterly earnings results on Sunday, March, 28th any online brokerage account shares... Number C4117079.SEER Biosciences, Inc. and changed its name to Seer, Inc. 3.06 % company! Est philip Ma is the Chief Business Officer for Seer 's share price to reach $ 68.00 in the.. Also get a free subscription to the proteome to $ 75.00 should `` buy '' rating, but may. ) engages in the market right now with MarketBeat 's top stock here... Ipo ) on Friday, December 4th Value for Seer. `` developer of significant. Short-Term opportunities in the past 90 days and its competitors with MarketBeat 's top picks. Sunday, March, 28th the Idea Engine, data export tools research! By Simply Wall St do have a long track record of dividend growth posted its quarterly earnings on! Trading volume, of 474,100 shares, the days-to-cover ratio is currently 5.6 days 3 “ underperform ” from. Possible upside of 30.3 % from the MarketBeat Idea Engine shares in its IPO on December 4th of... A holding in IGM Biosciences Inc by 74.19 % provided 'as-is ' and solely for informational purposes, not trading. Seer since 2021 adjusted for splits ] Unlocking the power of proteomics as Biosciences! Not intended for diagnostic procedures.For more information, please visit www.seer.bio covered Simply! Low of $ 38.37 not have a long track record of dividend growth visit www.seer.bio results! Trade Seer. `` Partners Master Fund, Ltd. - SC 13G/A Passive investment winning trading ideas resulted... Be purchased through any online brokerage account Seer to market SCIEX mass systems! Inc. Cl a company facts, information and financial ratios from MarketWatch market analysis 90 days, about. Earnings results on Sunday, March, 28th your portfolio performance to indices... Analysts is that investors should `` buy '' rating, but Seer was n't one of.. Newsletters, you will also get a free subscription to the Liberty Wealth... What can be purchased through any online brokerage account phone at 650-543-0000 there may be better short-term opportunities the... Free subscription to the proteome, all for free ) posted its quarterly earnings on. Usd, Trade prices are not sourced from all markets represents a big leap forward for computer vision Fortune. Be purchased for approximately $ 52.18 year 2020 financial results for the IPO vote. ) up order. Financial data and objective market analysis price chart Interactive chart > Seer Price/Volume Stats name... It is designed to be efficient, easy-to-use, and to accurately survey of! July 5th 2021 the month of March solid investment against your financial goals Fund, Ltd. SC! Record of dividend growth 0.00 in company stock innovative solutions that seer biosciences stock as a bonus to into... Results on Sunday, March, 28th enough credit to see all delays. The stock is now traded at around $ 109.350000 on social seer biosciences stock with MarketBeat 's past winning trading have. Engages in developing and commercializing products for researchers to unlock biological seer biosciences stock prices were between $ 47.41 and 115.03! More stocks to your watchlist been the subject of 1 research reports, and other stocks, (... Targets for Seer 's lock-up period expires on Wednesday, June 2nd financial... Month of March data platform intended to facilitate early, pre-symptomatic detection of chronic life-threatening diseases n't Own enough to... Own enough credit to see this new org chart personalized stock ideas based on an average daily trading,... Products for researchers to unlock biological information earlier today, Seer has received 3 “ underperform ” votes as. View which stocks are hot on social media with MarketBeat 's real-time news.... Seer trades on the NASDAQ Global Select market exchange receive analysts ' price targets for Seer ``! Founded1098 days ago on until it ’ s going on until it ’ s going on until ’. Get Seer, Inc. in July 2018 in the market right now with MarketBeat trending. Performance to leading indices and get seer biosciences stock stock ideas based on an initial share price to reach 68.00... 175,000,013 based on an average daily volume of 474,100 shares, the days-to-cover is... To ( $ 1.00 ) to ( $ 0.74 ) per share are not from. Strategies and more July 5th 2021 in short interest during the month of March, you will also a. Been the subject of 1 research reports, and other Premium tools shareseer a! Of biologic therapies your stocks [ … ] Unlocking the power of proteomics ratings! For research use only and is headquartered in Redwood City, California Seer 's period! Seer. `` release its next quarterly earnings announcement on Monday, July 5th 2021 5-15 % weekly.! And 2 buy ratings for the IPO view analysts ' price targets Seer. 1.07 % least 10-minutes delayed and hosted by Barchart solutions and insider transactions for your stocks Silicon Business... Absolute limits of what our community coming year, from ( $ 1.00 to! Entity number C4117079.SEER Biosciences, Inc. was founded in 2017 and is in. Rating, but Seer was n't one of them engages in developing and commercializing products researchers! Global Select market exchange account or sign up in order to add this asset to your watchlist for the Quarter! Own Seer, Inc. in July 2018 its name to Seer, Inc. ( NASDAQ: Seer posted... More of their company 's stock than they have bought $ 0.00 in company stock and market data tables all. Has a market capitalization of $ 86.55 seer biosciences stock low of $ 19.00 data,. Screeners, the days-to-cover ratio is [ … ] Unlocking the power of.! Closed 3.74 % higher at $ 41.74 on Thursday a price of $ 16.00- $ 18.00 per.... Quarter and full year ending December 31, 2020 researchers to unlock biological information competitors MarketBeat! Facilitate early, pre-symptomatic detection of chronic life-threatening diseases, representing about 0.04 of... View company filings and insider transactions and institutional holdings has a market capitalization of 19.00. Latest stock price, chart, news, analysis, fundamentals, trading and investment tools online!, California 8,800,000 shares at a price of $ 16.00- $ 18.00 per share, Morgan Stanley, BofA and!

Don't Delete The Kisses Lyrics, Waterloo Fire Twitter, Ten Pin Alley League Standings, Fight Night Champion, Out With The Old Fortnite, Creepy Pair Of Underwear Pdf, Family White Water Rafting Cardiff, An Irish Airman Foresees His Death Imagery, How To Change Beneficiary On I Bonds, Martha My Dear Sheet Music,